Project
Illumina Body Map 2
Navigation
Downloads
Results for RUNX1_RUNX2
Z-value: 3.45
Motif logo
Transcription factors associated with RUNX1_RUNX2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
RUNX1
|
ENSG00000159216.14 | RUNX family transcription factor 1 |
|
RUNX2
|
ENSG00000124813.16 | RUNX family transcription factor 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| RUNX1 | hg19_v2_chr21_-_36421401_36421462 | 0.54 | 1.6e-03 | Click! |
| RUNX2 | hg19_v2_chr6_+_45389893_45389914 | 0.53 | 1.8e-03 | Click! |
Activity profile of RUNX1_RUNX2 motif
Sorted Z-values of RUNX1_RUNX2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr11_+_60739249 | 15.50 |
ENST00000542157.1
ENST00000433107.2 ENST00000452451.2 ENST00000352009.5 |
CD6
|
CD6 molecule |
| chr11_+_60739115 | 14.85 |
ENST00000344028.5
ENST00000346437.4 |
CD6
|
CD6 molecule |
| chr2_+_7865923 | 14.51 |
ENST00000417930.1
|
AC092580.4
|
AC092580.4 |
| chr2_-_89442621 | 14.36 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
| chrX_-_70838306 | 13.66 |
ENST00000373691.4
ENST00000373693.3 |
CXCR3
|
chemokine (C-X-C motif) receptor 3 |
| chr11_+_60739140 | 12.97 |
ENST00000313421.7
|
CD6
|
CD6 molecule |
| chr1_+_159770292 | 12.70 |
ENST00000536257.1
ENST00000321935.6 |
FCRL6
|
Fc receptor-like 6 |
| chr12_-_68553512 | 12.34 |
ENST00000229135.3
|
IFNG
|
interferon, gamma |
| chr1_-_114414316 | 11.96 |
ENST00000528414.1
ENST00000538253.1 ENST00000460620.1 ENST00000420377.2 ENST00000525799.1 ENST00000359785.5 |
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
| chr1_+_209929377 | 11.56 |
ENST00000400959.3
ENST00000367025.3 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
| chr2_+_90077680 | 11.29 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
| chr16_+_85942594 | 11.20 |
ENST00000566369.1
|
IRF8
|
interferon regulatory factor 8 |
| chr22_+_23114284 | 11.13 |
ENST00000390313.2
|
IGLV3-12
|
immunoglobulin lambda variable 3-12 |
| chr1_+_209929494 | 11.08 |
ENST00000367026.3
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
| chr17_-_46262541 | 10.24 |
ENST00000579336.1
|
SKAP1
|
src kinase associated phosphoprotein 1 |
| chr1_+_209929446 | 10.11 |
ENST00000479796.1
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
| chrX_-_49121165 | 9.99 |
ENST00000376207.4
ENST00000376199.2 |
FOXP3
|
forkhead box P3 |
| chr17_-_29641084 | 9.91 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
| chr17_-_29641104 | 9.88 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
| chr17_-_34417479 | 9.53 |
ENST00000225245.5
|
CCL3
|
chemokine (C-C motif) ligand 3 |
| chr6_-_41168920 | 9.52 |
ENST00000483722.1
|
TREML2
|
triggering receptor expressed on myeloid cells-like 2 |
| chr3_-_71834207 | 9.34 |
ENST00000295619.3
|
PROK2
|
prokineticin 2 |
| chr1_+_198608292 | 9.05 |
ENST00000418674.1
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
| chr2_-_158300556 | 9.01 |
ENST00000264192.3
|
CYTIP
|
cytohesin 1 interacting protein |
| chr5_-_39219705 | 8.88 |
ENST00000351578.6
|
FYB
|
FYN binding protein |
| chr12_-_53594227 | 8.81 |
ENST00000550743.2
|
ITGB7
|
integrin, beta 7 |
| chr1_+_198608146 | 8.74 |
ENST00000367376.2
ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
| chr5_-_39219641 | 8.74 |
ENST00000509072.1
ENST00000504542.1 ENST00000505428.1 ENST00000506557.1 |
FYB
|
FYN binding protein |
| chr14_+_22180536 | 8.67 |
ENST00000390424.2
|
TRAV2
|
T cell receptor alpha variable 2 |
| chr6_+_31543334 | 8.65 |
ENST00000449264.2
|
TNF
|
tumor necrosis factor |
| chr14_-_106312010 | 8.51 |
ENST00000390556.2
|
IGHD
|
immunoglobulin heavy constant delta |
| chr1_-_25291475 | 8.51 |
ENST00000338888.3
ENST00000399916.1 |
RUNX3
|
runt-related transcription factor 3 |
| chr5_+_35856951 | 8.47 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
| chr19_-_54804173 | 8.37 |
ENST00000391744.3
ENST00000251390.3 |
LILRA3
|
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 |
| chr12_+_129338008 | 8.25 |
ENST00000442111.2
ENST00000281703.6 |
GLT1D1
|
glycosyltransferase 1 domain containing 1 |
| chr4_-_84035868 | 8.22 |
ENST00000426923.2
ENST00000509973.1 |
PLAC8
|
placenta-specific 8 |
| chr8_-_134072593 | 8.18 |
ENST00000427060.2
|
SLA
|
Src-like-adaptor |
| chr16_+_29674540 | 8.03 |
ENST00000436527.1
ENST00000360121.3 ENST00000449759.1 |
SPN
QPRT
|
sialophorin quinolinate phosphoribosyltransferase |
| chr2_+_204571198 | 8.02 |
ENST00000374481.3
ENST00000458610.2 ENST00000324106.8 |
CD28
|
CD28 molecule |
| chr1_+_172628154 | 7.86 |
ENST00000340030.3
ENST00000367721.2 |
FASLG
|
Fas ligand (TNF superfamily, member 6) |
| chr2_+_204571375 | 7.74 |
ENST00000374478.4
|
CD28
|
CD28 molecule |
| chr16_+_31366455 | 7.74 |
ENST00000268296.4
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit) |
| chr4_-_84035905 | 7.55 |
ENST00000311507.4
|
PLAC8
|
placenta-specific 8 |
| chr17_-_34524157 | 7.55 |
ENST00000378354.4
ENST00000394484.1 |
CCL3L3
|
chemokine (C-C motif) ligand 3-like 3 |
| chr1_-_168513229 | 7.50 |
ENST00000367819.2
|
XCL2
|
chemokine (C motif) ligand 2 |
| chr14_-_25103472 | 7.43 |
ENST00000216341.4
ENST00000382542.1 ENST00000382540.1 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
| chr19_-_8567505 | 7.43 |
ENST00000600262.1
|
PRAM1
|
PML-RARA regulated adaptor molecule 1 |
| chr7_+_142012967 | 7.39 |
ENST00000390357.3
|
TRBV4-1
|
T cell receptor beta variable 4-1 |
| chr14_-_25078864 | 7.39 |
ENST00000216338.4
ENST00000557220.2 ENST00000382548.4 |
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX) |
| chr5_-_39203093 | 7.36 |
ENST00000515010.1
|
FYB
|
FYN binding protein |
| chr3_-_72150076 | 7.36 |
ENST00000488545.1
ENST00000608654.1 |
LINC00877
|
long intergenic non-protein coding RNA 877 |
| chr1_+_203734296 | 7.32 |
ENST00000442561.2
ENST00000367217.5 |
LAX1
|
lymphocyte transmembrane adaptor 1 |
| chr8_-_126963387 | 7.29 |
ENST00000522865.1
ENST00000517869.1 |
LINC00861
|
long intergenic non-protein coding RNA 861 |
| chr1_-_92951607 | 7.28 |
ENST00000427103.1
|
GFI1
|
growth factor independent 1 transcription repressor |
| chr19_-_51875894 | 7.21 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
| chr19_-_36233332 | 7.20 |
ENST00000592537.1
ENST00000246532.1 ENST00000344990.3 ENST00000588992.1 |
IGFLR1
|
IGF-like family receptor 1 |
| chr16_+_29674277 | 7.20 |
ENST00000395389.2
|
SPN
|
sialophorin |
| chr14_+_22508822 | 7.01 |
ENST00000390448.3
|
TRAV20
|
T cell receptor alpha variable 20 |
| chr14_-_50506589 | 7.01 |
ENST00000553914.2
|
RP11-58E21.3
|
RP11-58E21.3 |
| chr22_+_22453093 | 6.98 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
| chr17_-_73839792 | 6.98 |
ENST00000590762.1
|
UNC13D
|
unc-13 homolog D (C. elegans) |
| chr19_-_8567478 | 6.91 |
ENST00000255612.3
|
PRAM1
|
PML-RARA regulated adaptor molecule 1 |
| chr3_-_150920979 | 6.91 |
ENST00000309180.5
ENST00000480322.1 |
GPR171
|
G protein-coupled receptor 171 |
| chr14_+_22573582 | 6.88 |
ENST00000390453.1
|
TRAV24
|
T cell receptor alpha variable 24 |
| chr14_+_22337014 | 6.87 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
| chr8_-_126963487 | 6.75 |
ENST00000518964.1
|
LINC00861
|
long intergenic non-protein coding RNA 861 |
| chr17_-_62009621 | 6.73 |
ENST00000349817.2
ENST00000392795.3 |
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
| chr6_-_128222103 | 6.67 |
ENST00000434358.1
ENST00000543064.1 ENST00000368248.2 |
THEMIS
|
thymocyte selection associated |
| chr16_-_68033356 | 6.63 |
ENST00000393847.1
ENST00000573808.1 ENST00000572624.1 |
DPEP2
|
dipeptidase 2 |
| chr4_+_71091786 | 6.62 |
ENST00000317987.5
|
FDCSP
|
follicular dendritic cell secreted protein |
| chr14_-_25103388 | 6.60 |
ENST00000526004.1
ENST00000415355.3 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
| chr17_-_34625719 | 6.57 |
ENST00000422211.2
ENST00000542124.1 |
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1 |
| chr14_+_22748980 | 6.56 |
ENST00000390465.2
|
TRAV38-2DV8
|
T cell receptor alpha variable 38-2/delta variable 8 |
| chr6_+_27925019 | 6.55 |
ENST00000244623.1
|
OR2B6
|
olfactory receptor, family 2, subfamily B, member 6 |
| chr22_+_22385332 | 6.51 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
| chr1_+_17634689 | 6.45 |
ENST00000375453.1
ENST00000375448.4 |
PADI4
|
peptidyl arginine deiminase, type IV |
| chr22_+_23247030 | 6.44 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
| chr1_-_153517473 | 6.38 |
ENST00000368715.1
|
S100A4
|
S100 calcium binding protein A4 |
| chr19_+_7413835 | 6.35 |
ENST00000576789.1
|
CTB-133G6.1
|
CTB-133G6.1 |
| chr16_-_3306587 | 6.35 |
ENST00000541159.1
ENST00000536379.1 ENST00000219596.1 ENST00000339854.4 |
MEFV
|
Mediterranean fever |
| chr8_+_22435762 | 6.34 |
ENST00000456545.1
|
PDLIM2
|
PDZ and LIM domain 2 (mystique) |
| chr20_-_1600642 | 6.32 |
ENST00000381603.3
ENST00000381605.4 ENST00000279477.7 ENST00000568365.1 ENST00000564763.1 |
SIRPB1
RP4-576H24.4
|
signal-regulatory protein beta 1 Uncharacterized protein |
| chr5_-_149465990 | 6.22 |
ENST00000543093.1
|
CSF1R
|
colony stimulating factor 1 receptor |
| chr22_+_23063100 | 6.21 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
| chr16_+_23847267 | 6.15 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
| chr8_+_11351876 | 6.08 |
ENST00000529894.1
|
BLK
|
B lymphoid tyrosine kinase |
| chr12_-_109025849 | 6.08 |
ENST00000228463.6
|
SELPLG
|
selectin P ligand |
| chr16_+_23847339 | 6.02 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
| chr11_+_4470525 | 6.00 |
ENST00000325719.4
|
OR52K2
|
olfactory receptor, family 52, subfamily K, member 2 |
| chr22_+_23241661 | 5.99 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
| chr20_+_54987168 | 5.86 |
ENST00000360314.3
|
CASS4
|
Cas scaffolding protein family member 4 |
| chr19_-_42636543 | 5.86 |
ENST00000528894.4
ENST00000560804.2 ENST00000560558.1 ENST00000560398.1 ENST00000526816.2 |
POU2F2
|
POU class 2 homeobox 2 |
| chr16_+_27438563 | 5.82 |
ENST00000395754.4
|
IL21R
|
interleukin 21 receptor |
| chrX_+_48542168 | 5.80 |
ENST00000376701.4
|
WAS
|
Wiskott-Aldrich syndrome |
| chrX_-_19688475 | 5.78 |
ENST00000541422.1
|
SH3KBP1
|
SH3-domain kinase binding protein 1 |
| chr17_-_61776522 | 5.78 |
ENST00000582055.1
|
LIMD2
|
LIM domain containing 2 |
| chr4_-_38806404 | 5.75 |
ENST00000308979.2
ENST00000505940.1 ENST00000515861.1 |
TLR1
|
toll-like receptor 1 |
| chrX_+_135730297 | 5.72 |
ENST00000370629.2
|
CD40LG
|
CD40 ligand |
| chr8_-_126963417 | 5.67 |
ENST00000500989.2
|
LINC00861
|
long intergenic non-protein coding RNA 861 |
| chr17_-_72542278 | 5.65 |
ENST00000330793.1
|
CD300C
|
CD300c molecule |
| chr9_-_130541017 | 5.62 |
ENST00000314830.8
|
SH2D3C
|
SH2 domain containing 3C |
| chr8_+_11351494 | 5.62 |
ENST00000259089.4
|
BLK
|
B lymphoid tyrosine kinase |
| chr14_-_107013465 | 5.59 |
ENST00000390625.2
|
IGHV3-49
|
immunoglobulin heavy variable 3-49 |
| chr20_+_62716348 | 5.58 |
ENST00000349451.3
|
OPRL1
|
opiate receptor-like 1 |
| chr17_-_62009702 | 5.52 |
ENST00000006750.3
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
| chr1_-_145715565 | 5.44 |
ENST00000369288.2
ENST00000369290.1 ENST00000401557.3 |
CD160
|
CD160 molecule |
| chr11_+_35198243 | 5.42 |
ENST00000528455.1
|
CD44
|
CD44 molecule (Indian blood group) |
| chr19_-_14785698 | 5.35 |
ENST00000344373.4
ENST00000595472.1 |
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
| chr17_-_56494713 | 5.34 |
ENST00000407977.2
|
RNF43
|
ring finger protein 43 |
| chr1_+_206643787 | 5.30 |
ENST00000367120.3
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon |
| chr19_-_52255107 | 5.29 |
ENST00000595042.1
ENST00000304748.4 |
FPR1
|
formyl peptide receptor 1 |
| chr2_-_90538397 | 5.27 |
ENST00000443397.3
|
RP11-685N3.1
|
Uncharacterized protein |
| chr5_-_138725594 | 5.25 |
ENST00000302125.8
|
MZB1
|
marginal zone B and B1 cell-specific protein |
| chr1_+_168545711 | 5.23 |
ENST00000367818.3
|
XCL1
|
chemokine (C motif) ligand 1 |
| chr3_+_113251143 | 5.19 |
ENST00000264852.4
ENST00000393830.3 |
SIDT1
|
SID1 transmembrane family, member 1 |
| chr2_+_90153696 | 5.17 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
| chrX_+_135730373 | 5.16 |
ENST00000370628.2
|
CD40LG
|
CD40 ligand |
| chr1_-_173174681 | 5.14 |
ENST00000367718.1
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4 |
| chr2_+_87565634 | 5.13 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
| chr20_+_36932521 | 5.12 |
ENST00000262865.4
|
BPI
|
bactericidal/permeability-increasing protein |
| chr16_+_72088376 | 5.11 |
ENST00000570083.1
ENST00000355906.5 ENST00000398131.2 ENST00000569639.1 ENST00000564499.1 ENST00000357763.4 ENST00000562526.1 ENST00000565574.1 ENST00000568417.2 ENST00000356967.5 |
HP
HPR
|
haptoglobin haptoglobin-related protein |
| chr16_+_30194916 | 5.10 |
ENST00000570045.1
ENST00000565497.1 ENST00000570244.1 |
CORO1A
|
coronin, actin binding protein, 1A |
| chr11_+_35198118 | 5.09 |
ENST00000525211.1
ENST00000526000.1 ENST00000279452.6 ENST00000527889.1 |
CD44
|
CD44 molecule (Indian blood group) |
| chr4_-_109087445 | 5.07 |
ENST00000512172.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
| chr19_-_14785622 | 5.04 |
ENST00000443157.2
|
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
| chr5_+_156607829 | 4.98 |
ENST00000422843.3
|
ITK
|
IL2-inducible T-cell kinase |
| chr5_-_138725560 | 4.95 |
ENST00000412103.2
ENST00000457570.2 |
MZB1
|
marginal zone B and B1 cell-specific protein |
| chr2_+_89890533 | 4.94 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
| chr12_-_9760482 | 4.94 |
ENST00000229402.3
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1 |
| chr19_-_50868882 | 4.91 |
ENST00000598915.1
|
NAPSA
|
napsin A aspartic peptidase |
| chr2_-_89327228 | 4.89 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
| chr4_-_109087906 | 4.88 |
ENST00000515500.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
| chr14_-_107179265 | 4.85 |
ENST00000390634.2
|
IGHV2-70
|
immunoglobulin heavy variable 2-70 |
| chr12_+_47610315 | 4.84 |
ENST00000548348.1
ENST00000549500.1 |
PCED1B
|
PC-esterase domain containing 1B |
| chr20_+_54987305 | 4.84 |
ENST00000371336.3
ENST00000434344.1 |
CASS4
|
Cas scaffolding protein family member 4 |
| chr3_-_112218205 | 4.76 |
ENST00000383680.4
|
BTLA
|
B and T lymphocyte associated |
| chr3_-_112218378 | 4.75 |
ENST00000334529.5
|
BTLA
|
B and T lymphocyte associated |
| chr8_-_21771173 | 4.75 |
ENST00000518197.1
|
DOK2
|
docking protein 2, 56kDa |
| chr19_+_55417530 | 4.71 |
ENST00000350790.5
ENST00000338835.5 ENST00000357397.5 |
NCR1
|
natural cytotoxicity triggering receptor 1 |
| chr17_-_7017559 | 4.70 |
ENST00000446679.2
|
ASGR2
|
asialoglycoprotein receptor 2 |
| chr3_-_71834318 | 4.70 |
ENST00000353065.3
|
PROK2
|
prokineticin 2 |
| chr12_-_103889731 | 4.69 |
ENST00000552578.1
ENST00000548048.1 ENST00000315192.8 ENST00000548883.1 ENST00000378113.2 |
C12orf42
|
chromosome 12 open reading frame 42 |
| chr1_-_207095212 | 4.68 |
ENST00000420007.2
|
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
| chr6_+_45296048 | 4.65 |
ENST00000465038.2
ENST00000352853.5 ENST00000541979.1 ENST00000371438.1 |
RUNX2
|
runt-related transcription factor 2 |
| chr19_-_14785674 | 4.64 |
ENST00000253673.5
|
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
| chr18_-_68317947 | 4.64 |
ENST00000594039.1
ENST00000582578.1 |
GTSCR1
|
Gilles de la Tourette syndrome chromosome region, candidate 1 |
| chr2_-_89385283 | 4.62 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
| chr22_+_24823517 | 4.60 |
ENST00000496258.1
ENST00000337539.7 |
ADORA2A
|
adenosine A2a receptor |
| chr1_-_1690014 | 4.60 |
ENST00000400922.2
ENST00000342348.5 |
NADK
|
NAD kinase |
| chr1_-_235098935 | 4.59 |
ENST00000423175.1
|
RP11-443B7.1
|
RP11-443B7.1 |
| chr2_+_89196746 | 4.56 |
ENST00000390244.2
|
IGKV5-2
|
immunoglobulin kappa variable 5-2 |
| chr2_+_30455016 | 4.56 |
ENST00000401506.1
ENST00000407930.2 |
LBH
|
limb bud and heart development |
| chr11_+_65647280 | 4.54 |
ENST00000307886.3
ENST00000528419.1 ENST00000526034.1 |
CTSW
|
cathepsin W |
| chr14_+_21359558 | 4.51 |
ENST00000304639.3
|
RNASE3
|
ribonuclease, RNase A family, 3 |
| chr3_-_72149553 | 4.50 |
ENST00000468646.2
ENST00000464271.1 |
LINC00877
|
long intergenic non-protein coding RNA 877 |
| chr11_-_58345569 | 4.47 |
ENST00000528954.1
ENST00000528489.1 |
LPXN
|
leupaxin |
| chr20_+_44637526 | 4.45 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
| chr17_+_7239821 | 4.44 |
ENST00000158762.3
ENST00000570457.2 |
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
| chr19_+_52255261 | 4.41 |
ENST00000600258.1
|
FPR2
|
formyl peptide receptor 2 |
| chr22_+_22786288 | 4.40 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
| chrX_-_70331298 | 4.39 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
| chr3_+_186692745 | 4.39 |
ENST00000438590.1
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
| chr1_+_206643806 | 4.38 |
ENST00000537984.1
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon |
| chr17_+_7239904 | 4.38 |
ENST00000575425.1
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
| chr14_+_22670455 | 4.37 |
ENST00000390460.1
|
TRAV26-2
|
T cell receptor alpha variable 26-2 |
| chr14_+_22386325 | 4.36 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
| chr1_+_90098606 | 4.36 |
ENST00000370454.4
|
LRRC8C
|
leucine rich repeat containing 8 family, member C |
| chr22_+_22707260 | 4.30 |
ENST00000390293.1
|
IGLV5-48
|
immunoglobulin lambda variable 5-48 (non-functional) |
| chr14_+_22788560 | 4.28 |
ENST00000390468.1
|
TRAV41
|
T cell receptor alpha variable 41 |
| chr2_+_90211643 | 4.25 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
| chr7_-_36634181 | 4.23 |
ENST00000538464.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
| chr5_-_94417562 | 4.23 |
ENST00000505465.1
|
MCTP1
|
multiple C2 domains, transmembrane 1 |
| chr1_-_157522260 | 4.21 |
ENST00000368191.3
ENST00000361835.3 |
FCRL5
|
Fc receptor-like 5 |
| chr7_-_142176790 | 4.20 |
ENST00000390369.2
|
TRBV7-4
|
T cell receptor beta variable 7-4 (gene/pseudogene) |
| chr7_-_142207004 | 4.20 |
ENST00000426318.2
|
TRBV10-2
|
T cell receptor beta variable 10-2 |
| chr2_+_68592305 | 4.19 |
ENST00000234313.7
|
PLEK
|
pleckstrin |
| chr2_-_89278535 | 4.18 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
| chr8_+_27168988 | 4.17 |
ENST00000397501.1
ENST00000338238.4 ENST00000544172.1 |
PTK2B
|
protein tyrosine kinase 2 beta |
| chrX_+_37639302 | 4.17 |
ENST00000545017.1
ENST00000536160.1 |
CYBB
|
cytochrome b-245, beta polypeptide |
| chr20_-_1569278 | 4.14 |
ENST00000262929.5
ENST00000567028.1 |
SIRPB1
RP4-576H24.4
|
signal-regulatory protein beta 1 Uncharacterized protein |
| chr1_-_207095324 | 4.14 |
ENST00000530505.1
ENST00000367091.3 ENST00000442471.2 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
| chr6_-_154568815 | 4.12 |
ENST00000519344.1
|
IPCEF1
|
interaction protein for cytohesin exchange factors 1 |
| chr22_+_24038593 | 4.12 |
ENST00000452208.1
|
RGL4
|
ral guanine nucleotide dissociation stimulator-like 4 |
| chr5_-_43043272 | 4.10 |
ENST00000314890.3
|
ANXA2R
|
annexin A2 receptor |
| chr21_+_30502806 | 4.10 |
ENST00000399928.1
ENST00000399926.1 |
MAP3K7CL
|
MAP3K7 C-terminal like |
| chr19_-_52133588 | 4.10 |
ENST00000570106.2
|
SIGLEC5
|
sialic acid binding Ig-like lectin 5 |
| chr1_+_53098862 | 4.08 |
ENST00000517870.1
|
FAM159A
|
family with sequence similarity 159, member A |
| chr1_-_157522180 | 4.07 |
ENST00000356953.4
ENST00000368188.2 ENST00000368190.3 ENST00000368189.3 |
FCRL5
|
Fc receptor-like 5 |
| chr14_+_22919081 | 4.02 |
ENST00000390473.1
|
TRDJ1
|
T cell receptor delta joining 1 |
| chr2_+_103035102 | 4.01 |
ENST00000264260.2
|
IL18RAP
|
interleukin 18 receptor accessory protein |
| chr11_-_128457446 | 3.99 |
ENST00000392668.4
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
| chr20_-_62199427 | 3.97 |
ENST00000427522.2
|
HELZ2
|
helicase with zinc finger 2, transcriptional coactivator |
| chr8_-_21771214 | 3.97 |
ENST00000276420.4
|
DOK2
|
docking protein 2, 56kDa |
| chr2_-_73869508 | 3.96 |
ENST00000272425.3
|
NAT8
|
N-acetyltransferase 8 (GCN5-related, putative) |
| chr4_-_109087872 | 3.94 |
ENST00000510624.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
| chr18_-_67629015 | 3.93 |
ENST00000579496.1
|
CD226
|
CD226 molecule |
| chr19_-_52150053 | 3.87 |
ENST00000599649.1
ENST00000429354.3 ENST00000360844.6 ENST00000222107.4 |
SIGLEC5
SIGLEC14
SIGLEC5
|
SIGLEC5 sialic acid binding Ig-like lectin 14 sialic acid binding Ig-like lectin 5 |
| chr7_+_99971129 | 3.87 |
ENST00000394000.2
ENST00000350573.2 |
PILRA
|
paired immunoglobin-like type 2 receptor alpha |
| chr11_+_121447469 | 3.85 |
ENST00000532694.1
ENST00000534286.1 |
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
| chr14_-_106092403 | 3.82 |
ENST00000390543.2
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
Network of associatons between targets according to the STRING database.
First level regulatory network of RUNX1_RUNX2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.3 | 25.0 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
| 5.0 | 15.0 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 3.9 | 15.7 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 3.7 | 29.8 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 3.5 | 14.2 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
| 3.4 | 13.4 | GO:0071661 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 3.0 | 12.0 | GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) positive regulation of protein K63-linked ubiquitination(GO:1902523) |
| 3.0 | 11.9 | GO:0002432 | granuloma formation(GO:0002432) |
| 2.9 | 8.8 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
| 2.9 | 14.4 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 2.6 | 47.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 2.4 | 7.3 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 2.4 | 7.3 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
| 2.2 | 6.5 | GO:0002818 | intracellular defense response(GO:0002818) |
| 2.1 | 6.3 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 2.0 | 15.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 2.0 | 13.9 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 2.0 | 7.9 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 2.0 | 7.9 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 1.9 | 3.8 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 1.8 | 5.4 | GO:1902960 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 1.7 | 5.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 1.7 | 5.1 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 1.6 | 4.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 1.6 | 15.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 1.5 | 29.3 | GO:0043383 | negative T cell selection(GO:0043383) |
| 1.5 | 6.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 1.5 | 4.5 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
| 1.5 | 7.5 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.4 | 5.8 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 1.4 | 7.2 | GO:0039650 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 1.4 | 5.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 1.3 | 7.9 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 1.3 | 7.7 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 1.2 | 3.6 | GO:1903216 | negative regulation of late endosome to lysosome transport(GO:1902823) regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 1.2 | 4.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 1.2 | 5.8 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.2 | 10.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.2 | 3.5 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 1.2 | 1.2 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 1.2 | 2.3 | GO:0060389 | pathway-restricted SMAD protein phosphorylation(GO:0060389) |
| 1.1 | 2.3 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 1.1 | 1.1 | GO:0002859 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 1.1 | 12.3 | GO:0070269 | pyroptosis(GO:0070269) |
| 1.1 | 13.0 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 1.1 | 11.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 1.1 | 6.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 1.0 | 2.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
| 1.0 | 16.4 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 1.0 | 5.1 | GO:0061502 | uropod organization(GO:0032796) early endosome to recycling endosome transport(GO:0061502) |
| 1.0 | 2.0 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 1.0 | 4.9 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 1.0 | 2.9 | GO:1904604 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.9 | 17.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.9 | 6.4 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 0.9 | 2.7 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.9 | 2.7 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.9 | 4.5 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.9 | 3.5 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.9 | 2.7 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
| 0.9 | 3.5 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.9 | 2.6 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.8 | 3.3 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.8 | 8.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.8 | 2.5 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.8 | 16.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.8 | 4.0 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.8 | 7.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.8 | 0.8 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
| 0.8 | 6.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.8 | 3.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.7 | 5.2 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.7 | 3.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.7 | 2.2 | GO:2000627 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.7 | 4.4 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.7 | 6.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.7 | 29.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.7 | 9.3 | GO:0002855 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.7 | 16.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.7 | 2.1 | GO:0035700 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
| 0.7 | 2.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.7 | 2.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.7 | 2.0 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.7 | 4.7 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.7 | 8.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.7 | 2.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.7 | 4.6 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.7 | 2.0 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.6 | 3.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.6 | 1.9 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.6 | 1.3 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.6 | 3.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.6 | 1.2 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.6 | 3.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.6 | 6.5 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.6 | 90.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.6 | 10.3 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.6 | 4.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.6 | 2.2 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.6 | 5.6 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.6 | 1.7 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.5 | 27.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.5 | 1.6 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
| 0.5 | 6.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.5 | 2.1 | GO:0052363 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.5 | 2.7 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.5 | 3.1 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.5 | 4.7 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.5 | 2.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.5 | 7.7 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.5 | 11.8 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
| 0.5 | 1.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.5 | 3.6 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.5 | 1.5 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.5 | 4.0 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.5 | 2.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.5 | 1.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.5 | 2.0 | GO:0050705 | negative regulation of interleukin-1 alpha production(GO:0032690) regulation of interleukin-1 alpha secretion(GO:0050705) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.5 | 4.9 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.5 | 40.5 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.5 | 1.9 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.5 | 1.4 | GO:1901656 | cellular response to mycotoxin(GO:0036146) glycoside transport(GO:1901656) cellular response to bile acid(GO:1903413) |
| 0.5 | 1.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.5 | 1.9 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
| 0.5 | 9.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.5 | 102.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
| 0.5 | 1.4 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.5 | 8.7 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.5 | 3.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.5 | 1.8 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.5 | 1.4 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.5 | 1.4 | GO:0045925 | positive regulation of female receptivity(GO:0045925) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.4 | 1.8 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.4 | 3.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.4 | 1.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.4 | 3.1 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.4 | 2.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.4 | 9.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.4 | 2.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.4 | 1.7 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.4 | 7.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.4 | 12.5 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
| 0.4 | 6.2 | GO:0072678 | T cell migration(GO:0072678) |
| 0.4 | 0.8 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.4 | 0.4 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.4 | 1.6 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.4 | 1.2 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.4 | 1.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.4 | 5.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.4 | 36.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.4 | 1.2 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.4 | 2.3 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.4 | 1.2 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.4 | 1.6 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
| 0.4 | 1.6 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.4 | 1.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.4 | 1.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.4 | 3.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.4 | 1.5 | GO:0050707 | regulation of cytokine secretion(GO:0050707) |
| 0.4 | 3.7 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.4 | 1.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.4 | 1.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.4 | 10.7 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.4 | 1.1 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.4 | 2.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.4 | 1.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.4 | 1.4 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.4 | 1.4 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.4 | 1.1 | GO:1902004 | regulation of beta-amyloid formation(GO:1902003) positive regulation of beta-amyloid formation(GO:1902004) |
| 0.3 | 1.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.3 | 1.7 | GO:1905071 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.3 | 2.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.3 | 4.9 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.3 | 1.0 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.3 | 1.0 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.3 | 0.3 | GO:0035566 | regulation of metanephros size(GO:0035566) |
| 0.3 | 8.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.3 | 5.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.3 | 1.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.3 | 2.2 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.3 | 0.9 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.3 | 0.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.3 | 4.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.3 | 6.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.3 | 2.1 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.3 | 0.9 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.3 | 1.2 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.3 | 2.4 | GO:0046618 | drug export(GO:0046618) |
| 0.3 | 1.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.3 | 1.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.3 | 1.2 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.3 | 3.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.3 | 1.7 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.3 | 4.0 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.3 | 3.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.3 | 1.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
| 0.3 | 0.3 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.3 | 3.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.3 | 0.8 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.3 | 1.4 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.3 | 1.3 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.3 | 0.8 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.3 | 1.8 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 0.3 | 1.0 | GO:0071348 | response to interleukin-11(GO:0071105) cellular response to interleukin-11(GO:0071348) |
| 0.3 | 1.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.3 | 1.5 | GO:0019050 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
| 0.3 | 0.8 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
| 0.2 | 3.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.2 | 1.0 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.2 | 4.7 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
| 0.2 | 3.0 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
| 0.2 | 3.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.2 | 1.2 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.2 | 2.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.2 | 2.4 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
| 0.2 | 0.7 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.2 | 1.7 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.2 | 2.6 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.2 | 2.6 | GO:0002507 | tolerance induction(GO:0002507) |
| 0.2 | 0.7 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.2 | 3.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.2 | 1.2 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.2 | 0.9 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.2 | 16.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.2 | 11.6 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.2 | 1.6 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.2 | 1.6 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.2 | 4.1 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 | 0.9 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.2 | 1.1 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.2 | 9.1 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
| 0.2 | 15.5 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.2 | 2.3 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 0.7 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.2 | 2.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 0.2 | 1.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.2 | 3.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.2 | 3.9 | GO:0015816 | glycine transport(GO:0015816) |
| 0.2 | 1.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 | 0.9 | GO:0060022 | hard palate development(GO:0060022) |
| 0.2 | 5.1 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 | 6.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.2 | 4.4 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.2 | 2.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.2 | 0.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.2 | 2.3 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.2 | 0.6 | GO:0070839 | spleen trabecula formation(GO:0060345) divalent metal ion export(GO:0070839) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.2 | 7.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 1.6 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.2 | 0.8 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 0.2 | 5.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.2 | 3.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.2 | 0.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.2 | 0.4 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.2 | 5.8 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.2 | 1.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.2 | 4.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.2 | 2.1 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.2 | 3.2 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 | 0.9 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.2 | 2.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 | 1.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.2 | 0.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.2 | 0.5 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.2 | 0.7 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.2 | 2.0 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.2 | 0.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.2 | 0.7 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 | 5.3 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.2 | 2.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.2 | 2.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.2 | 0.5 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 | 1.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.2 | 0.9 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.2 | 1.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.2 | 6.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.2 | 2.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 | 0.8 | GO:0007584 | response to nutrient(GO:0007584) |
| 0.2 | 1.6 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.2 | 0.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.2 | 3.4 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.2 | 0.8 | GO:0045007 | depurination(GO:0045007) |
| 0.2 | 2.4 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.2 | 3.0 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.2 | 0.5 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
| 0.2 | 3.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.2 | 5.9 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.2 | 1.1 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.2 | 1.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.2 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.2 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.2 | 1.4 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.2 | 0.8 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.2 | 0.9 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.1 | 0.1 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.1 | 0.9 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.1 | 1.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 1.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 | 0.7 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 | 0.6 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 0.1 | 2.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.1 | 3.1 | GO:0072574 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
| 0.1 | 8.2 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) negative regulation of leukocyte proliferation(GO:0070664) |
| 0.1 | 2.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.1 | 0.8 | GO:0043585 | nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) |
| 0.1 | 3.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 1.3 | GO:0046075 | dTTP metabolic process(GO:0046075) |
| 0.1 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 | 0.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.1 | 1.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 | 0.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 | 0.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 0.1 | 2.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 | 1.9 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.1 | 0.9 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 1.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 1.3 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
| 0.1 | 0.3 | GO:0002501 | MHC protein complex assembly(GO:0002396) peptide antigen assembly with MHC protein complex(GO:0002501) |
| 0.1 | 0.4 | GO:1903708 | positive regulation of hemopoiesis(GO:1903708) |
| 0.1 | 2.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.1 | 0.9 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 3.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 | 0.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.1 | 0.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.1 | 3.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.1 | 2.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 | 8.5 | GO:0070671 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
| 0.1 | 83.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.1 | 0.8 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.1 | 0.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.1 | 0.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.1 | 1.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 5.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.1 | 0.3 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 0.1 | 0.9 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.1 | 4.6 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 0.8 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 0.7 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.1 | 0.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 | 1.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.1 | 0.6 | GO:0010816 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 | 0.8 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
| 0.1 | 1.4 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 | 1.7 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 2.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.1 | 0.4 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.1 | 0.2 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.1 | 7.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 3.7 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
| 0.1 | 0.8 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 0.9 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
| 0.1 | 0.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 | 1.4 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.1 | 0.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 | 0.7 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.1 | 1.9 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
| 0.1 | 1.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 9.7 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.1 | 0.8 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 | 2.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.1 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 | 0.9 | GO:1902363 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.1 | 1.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.1 | 0.8 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 0.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 0.1 | 1.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 | 5.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.1 | 1.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 0.6 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.1 | 0.3 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.1 | 0.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 1.7 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 0.7 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.8 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.1 | 6.4 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.1 | 9.9 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.1 | 0.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.1 | 0.5 | GO:0048565 | digestive tract development(GO:0048565) |
| 0.1 | 0.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.1 | 0.6 | GO:0015677 | copper ion import(GO:0015677) |
| 0.1 | 5.8 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.1 | 3.0 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.1 | 3.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 |